Structural basis for induced formation of the inflammatory mediator prostaglandin E2

Prostaglandins (PG) are bioactive lipids produced from arachidonic acid via the action of cyclooxygenases and terminal PG synthases. Microsomal prostaglandin E synthase 1 (MPGES1) constitutes an inducible glutathione-dependent integral membrane protein that catalyzes the oxidoreduction of cyclooxygenase derived PGH2 into PGE2. MPGES1 has been implicated in a number of human diseases or pathological conditions, such as rheumatoid arthritis, fever, and pain, and is therefore regarded as a primary target for development of novel antiinflammatory drugs. To provide a structural basis for insight in the catalytic mechanism, we determined the structure of MPGES1 in complex with glutathione by electron crystallography from 2D crystals induced in the presence of phospholipids. Together with results from site-directed mutagenesis and activity measurements, we can thereby demonstrate the role of specific amino acid residues. Glutathione is found to bind in a U-shaped conformation at the interface between subunits in the protein trimer. It is exposed to a site facing the lipid bilayer, which forms the specific environment for the oxidoreduction of PGH2 to PGE2 after displacement of the cytoplasmic half of the N-terminal transmembrane helix. Hence, insight into the dynamic behavior of MPGES1 and homologous membrane proteins in inflammation and detoxification is provided.

[1]  Chang-Guo Zhan,et al.  Structural and functional characterization of human microsomal prostaglandin E synthase-1 by computational modeling and site-directed mutagenesis. , 2006, Bioorganic & medicinal chemistry.

[2]  M. Murakami,et al.  Coupling between cyclooxygenases and terminal prostanoid synthases. , 2005, Biochemical and biophysical research communications.

[3]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[4]  Y. Fujiyoshi,et al.  The projection structure of the membrane protein microsomal glutathione transferase at 3 A resolution as determined from two-dimensional hexagonal crystals. , 1999, Journal of molecular biology.

[5]  B. Samuelsson,et al.  Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R A Crowther,et al.  MRC image processing programs. , 1996, Journal of structural biology.

[7]  R. Armstrong,et al.  Location of substrate binding sites within the integral membrane protein microsomal glutathione transferase-1. , 2007, Biochemistry.

[8]  W. Kühlbrandt,et al.  Human leukotriene C(4) synthase at 4.5 A resolution in projection. , 2004, Structure.

[9]  L. Crofford,et al.  Microsomal Prostaglandin E Synthase Is Regulated by Proinflammatory Cytokines and Glucocorticoids in Primary Rheumatoid Synovial Cells1 , 2001, The Journal of Immunology.

[10]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[11]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[12]  H. Hebert,et al.  The structure of membrane associated proteins in eicosanoid and glutathione metabolism as determined by electron crystallography. , 2007, Current opinion in structural biology.

[13]  Ralf Morgenstern,et al.  Bioinformatic and enzymatic characterization of the MAPEG superfamily , 2005, The FEBS journal.

[14]  L. Hedstrom,et al.  A twisted base? The role of arginine in enzyme-catalyzed proton abstractions. , 2005, Archives of biochemistry and biophysics.

[15]  R. Armstrong,et al.  Stress sensor triggers conformational response of the integral membrane protein microsomal glutathione transferase 1. , 2004, Biochemistry.

[16]  E. Herlenius,et al.  The induced prostaglandin E2 pathway is a key regulator of the respiratory response to infection and hypoxia in neonates , 2007, Proceedings of the National Academy of Sciences.

[17]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[18]  Jesper Z. Haeggström,et al.  Structural basis for synthesis of inflammatory mediators by human leukotriene C4 synthase , 2007, Nature.

[19]  J. Morrow,et al.  Metabolism of the Endocannabinoids, 2-Arachidonylglycerol and Anandamide, into Prostaglandin, Thromboxane, and Prostacyclin Glycerol Esters and Ethanolamides* , 2002, The Journal of Biological Chemistry.

[20]  Y. Ohmiya,et al.  Crystal structure and possible catalytic mechanism of microsomal prostaglandin E synthase type 2 (mPGES-2). , 2005, Journal of molecular biology.

[21]  Makoto Murakami,et al.  Regulation of Prostaglandin E2 Biosynthesis by Inducible Membrane-associated Prostaglandin E2 Synthase That Acts in Concert with Cyclooxygenase-2* , 2000, The Journal of Biological Chemistry.

[22]  Ralf Morgenstern,et al.  Structural basis for detoxification and oxidative stress protection in membranes. , 2006, Journal of molecular biology.

[23]  I. Lundberg,et al.  Effects of immunosuppressive treatment on microsomal PGE synthase 1 and cyclooxygenases expression in muscle tissue of patients with polymyositis or dermatomyositis , 2007 .

[24]  B. Persson,et al.  Common structural features of mapeg—a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism , 2008, Protein science : a publication of the Protein Society.

[25]  Y. Fujiyoshi,et al.  Trehalose embedding technique for high-resolution electron crystallography: application to structural study on bacteriorhodopsin. , 1999, Journal of electron microscopy.

[26]  Ralf Morgenstern,et al.  Human Microsomal Prostaglandin E Synthase-1 , 2003, Journal of Biological Chemistry.

[27]  L. Klareskog,et al.  Effects of antirheumatic treatments on the prostaglandin E2 biosynthetic pathway. , 2005, Arthritis and rheumatism.

[28]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[29]  P. Jakobsson,et al.  Effects of immunosuppressive treatment on microsomal prostaglandin E synthase 1 and cyclooxygenases expression in muscle tissue of patients with polymyositis or dermatomyositis , 2007, Annals of the rheumatic diseases.

[30]  Ralf Morgenstern,et al.  Membrane Prostaglandin E Synthase-1: A Novel Therapeutic Target , 2007, Pharmacological Reviews.

[31]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[32]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[33]  Jilly F. Evans,et al.  Crystal Structure of Inhibitor-Bound Human 5-Lipoxygenase-Activating Protein , 2007, Science.

[34]  Masashi Miyano,et al.  Crystal structure of a human membrane protein involved in cysteinyl leukotriene biosynthesis , 2007, Nature.

[35]  P. Jakobsson,et al.  Coordinate up- and down-regulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells. Inhibition by NS-398 and leukotriene C4. , 2000, European journal of biochemistry.

[36]  Y. Fujiyoshi,et al.  The 3.0 A projection structure of microsomal glutathione transferase as determined by electron crystallography of p 21212 two-dimensional crystals. , 1997, Journal of molecular biology.